These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20008213)

  • 21. Management of acute ischaemic stroke.
    Al Mahdy H
    Br J Hosp Med (Lond); 2009 Oct; 70(10):572-7. PubMed ID: 19966702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medical prevention of stroke and stroke recurrence in patients with TIA and minor stroke.
    Weber R; Weimar C; Diener HC
    Expert Opin Pharmacother; 2009 Aug; 10(12):1883-94. PubMed ID: 19558342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.
    Diener HC; Foerch C; Riess H; Röther J; Schroth G; Weber R
    Lancet Neurol; 2013 Jul; 12(7):677-88. PubMed ID: 23726849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug therapy of neurovascular disease.
    Weinberger J; Frishman WH; Terashita D
    Cardiol Rev; 2003; 11(3):122-46. PubMed ID: 12705843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.
    Fisher M; Folland E
    Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients.
    Pan Y; Chen Q; Liao X; Zhao X; Wang C; Liu G; Liu L; Wang C; Wang D; Wang Y; Wang Y;
    Neurol Res; 2015 Jan; 37(1):64-8. PubMed ID: 24861494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke prophylaxis: hypertension management and antithrombotic therapy.
    Tortorice KL; Carter BL
    Ann Pharmacother; 1993 Apr; 27(4):471-9. PubMed ID: 8477126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic drugs for the secondary prevention of ischemic stroke.
    Nenci GG; Goracci S
    Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
    Diener HC; Sacco R; Yusuf S; ;
    Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug therapy of neurovascular disease.
    Weinberger J; Terashita D
    Heart Dis; 1999; 1(3):163-78. PubMed ID: 11720620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Patent foramen ovale and stroke].
    Mono ML; Nedeltchev K
    Fortschr Neurol Psychiatr; 2012 May; 80(5):288-99. PubMed ID: 22566139
    [No Abstract]   [Full Text] [Related]  

  • 32. Protecting the brain and the heart: antithrombotic treatment in nonvalvular atrial fibrillation.
    Safouris A; Anagnostis P; Karlovasitou A; Karras S; Karagiannis A
    Angiology; 2014 May; 65(5):372-8. PubMed ID: 23620311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in stroke therapy.
    Goldszmidt A; Wityk RJ
    Curr Opin Neurol; 1998 Feb; 11(1):57-64. PubMed ID: 9484618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New agents and challenges in the antithrombotic management of arterial diseases].
    Udvardy M; Rák K
    Orv Hetil; 1997 Jan; 138(2):59-65. PubMed ID: 9064617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
    Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
    Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Stroke prevention].
    Arnold M; Nedeltchev K; Lyrer P; Baumgartner RW
    Ther Umsch; 2003 Sep; 60(9):521-6. PubMed ID: 14579620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. American Heart Association issues management guidelines for acute ischemic stroke.
    Am Fam Physician; 1995 Apr; 51(5):1301-4. PubMed ID: 7709897
    [No Abstract]   [Full Text] [Related]  

  • 39. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
    Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
    Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.